Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy

Prostate

Volumn 38, Issue 3, 1999, Pages 183-188

  Stege, Reinhard H ^a   Tribukait, Bernhard ^a   Carlström, Kjell A M ^a   Grande, Mirtha ^a   Pousette, Åke H L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biopsy; Prostatic neoplasm; PSA; Serum

Indexed keywords

DNA; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLOOD LEVEL; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DIPLOIDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PLOIDY; PRIORITY JOURNAL; PROSTATE CARCINOMA; TETRAPLOIDY; TUMOR VASCULARIZATION;

BIOPSY, NEEDLE; CYTODIAGNOSIS; DNA, NEOPLASM; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PLOIDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0033557320     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990215)38:3<183::AID-PROS2>3.0.CO;2-W     Document Type: Article

References (19)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a prostate specific antigen. Invest Urol 1979;17:159-163.
2. Bangma C, Blijenberg B, Schröder F. Prostate-specific antigen: its clinical use and application in screening for prostate cancer. Scand J Clin Lab Invest 1995;55[Suppl 221]:35-44.
3. Stein BS, Petersen RO, Vangore S, Kendall AR. Immunoperoxidase localization of prostate-specific antigen. Am J Surg Pathol 1982;6:553-557.
4. Ford TF, Butcher DN, Masters JRW, Parkinson MC. Immunocytochemical localisation of prostate-specific antigen: specificty and application to clinical practice. Br J Urol 1985;57:50-55.
5. Hasenson M, Lundh B, Stege R, Carlström K, Pousette Å. PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading. Prostate 1989;14:83-90.
6. Stege R, Lundh B, Tribukait B, Pousette Å, Carlström K, Hasenson M. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phophatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma. J Urol 1990;144:299-302.
7. Stege R, Tribukait B, Lundh B, Carlström K, Pousette Å, Hasenson M: Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytological grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma. J Urol 1992;148:833-837.
8. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G. UICC TNM Atlas, 7th ed. Berlin: Springer-Verlag; 1989. p 220-226.
9. Franzén S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumors by transrectal aspiration biopsy: a preliminary report. Br J Urol 1960;32:193-196.
10. Esposti PL. Cytological malignancy grading of prostatic carcinoma by transrectal aspiration biopsy: a five-year follow-up of 469 hormone-treated patients. Scand J Urol Nephrol 1971:5:199-202.
11. Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. In: Koss LG, Coleman DV, editors. Advances in clinical cytology. New York: Masson; 1984. p 163-169.
12. Labarca C, Pagen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980;102:344-352.
13. Malm J, Lilja H. Biochemistry of prostate specific antigen, PSA. Scand J Clin Lab Invest 1995;55[Suppl 221]:15-22.
14. Qiu S-D, Young CY-F, Bilhartz DL, Prescott JL, Farrow GM, He W-W, Tindall DJ. In situ hybridization of prostate specific antigen mRNA in human prostate. J Urol 1990;144:1550-1556.
15. Chan DW, Sokol LJ. Prostate-specific antigen: update 1997. J Int Fed Clin Chem 1997;9:120-125.
16. Diem K, Lentner C. Ciba-Geigy wissenschaftliche Tabellen, 7 Ausgabe [Ciba-Geigy scientific tables, 7th ed]. Stuttgart: Georg Thieme Verlag; 1975. p 581.
17. Porter JR, Brawer MK. Prostatic intraepithelial neoplasia and prostate-specific antigen. World J Urol 1993;11:196-200.
18. Van Iersel MP, Thomas CMG, Witjes R, de Graad R, de la Rosette JJMHC, Debruyne FMJ. Clinical implications of the rise and fall of prostatic specific antigen after laser prostatectomy. Br J Urol 1996;78:742-746.
19. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993:24:220-225.